Medicinal chemistry of competitive kainate receptor antagonists.
Kainic acid (KA) receptors belong to the group of ionotropic glutamate receptors and are expressed throughout in the central nervous system (CNS). The KA receptors have been shown to be involved in neurophysiological functions such as mossy fiber long-term potentiation (LTP) and synaptic plasticity and are thus potential therapeutic targets in CNS diseases such as schizophrenia, major depression, neuropathic pain and epilepsy. Extensive effort has been made to develop subtype-selective KA receptor antagonists in order to elucidate the physiological function of each of the five subunits known (GluK1-5). However, to date only selective antagonists for the GluK1 subunit have been discovered, which underlines the strong need for continued research in this area. The present review describes the structure-activity relationship and pharmacological profile for 10 chemically distinct classes of KA receptor antagonists comprising, in all, 45 compounds. To the medicinal chemist this information will serve as reference guidance as well as an inspiration for future effort in this field.
Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
Ann M
AM
Larsen
Lennart
L
Bunch
D000818:Animals; D001667:Binding, Competitive / Q000502:physiology; D002626:Chemistry, Pharmaceutical / Q000379:methods / Q000639:trends*; D018360:Crystallography, X-Ray; D006801:Humans; D011810:Quinoxalines / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D018092:Kainic Acid Receptors / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D013329:Structure-Activity Relationship
D011810:Quinoxalines; D018092:Kainic Acid Receptors